Diagnostic Test Calculator
Links shared publicly online about this topic.
- 1,658total visits
Diagnostic Test Calculator
View full resource at araw.mede.uic.edu
Tags: Brain
Most Recently Shared on October 22, 2009 at 1:42 pm By:
@guylene2 nice diagnostic test calculator here http://tinyurl.com/yf4uc4m for likliehood ratios etc [my brain now mildly fried] #CEBM09
Migraines Patient Education | Tests or Labs to Diagnose Headaches
vitals.com — “Read about the most common tests and labs to diagnose migraines and headaches such as MRI, ESR and CT Scans. Vitals patient information guide.” View full resource at vitals.com
Most Recently Shared on April 18, 2012 at 11:35 am By:
GenMark + Advanced Liquid Logic to Develop All-Electronic, Fully Integrated Dx Platform | IVD Technology
ivdtechnology.com — “GenMark Diagnostics Inc. and Advanced Liquid Logic Inc. are collaborating to develop an all-electronic, fully integrated IVD platform combining Advanced Liquid Logic’s proprietary electrowetting technology and GenMark’s proprietary electrochemical detection. GenMark is a provider of automated, multiplex molecular-dx testing systems that detect and measure DNA and RNA targets to diagnose disease and personalize patient treatment.” View full resource at ivdtechnology.com
Most Recently Shared on April 9, 2012 at 5:30 pm By:
IVD Technology Health Magazine
GenMark + Advanced Liquid Logic to Develop All-Electronic, Fully Integrated Dx Platform http://t.co/wpKVUgKY
Diagnostic Scans Tied to Radiation Risk for Gastro Patients - Yahoo! News
news.yahoo.com — “From Yahoo! News: FRIDAY, April 6 (HealthDay News) -- Patients with digestive disorders such as inflammatory bowel disease may be exposed to significant levels of radiation from diagnostic imaging tests, a new study suggests.” View full resource at news.yahoo.com
Most Recently Shared on April 6, 2012 at 5:35 pm By:
Diagnostic Scans Tied to Radiation Risk for Gastro Patients: FRIDAY, April 6 (HealthDay News) -- Patients with d... http://t.co/deUH0136
Genome-Based Diagnostics: Clarifying Pathways to Clinical Use - Workshop Report - Institute of Medicine
iom.edu — “New technologies are improving our ability to provide personalized treatment catered to an individual patient. Based on findings from the sequencing of the human genome, genome-based diagnostic tests have the potential to direct therapeutic interventions, predict risk or onset of disease, or detect residual disease. However, because evidence is lacking to show that these tests lead to an improved outcome, adoption has been limited. On November 15, 2011, the IOM held a workshop to discuss the dif” View full resource at iom.edu
Most Recently Shared on March 26, 2012 at 9:09 pm By:
P. F. Anderson Health Social Media
Genome-based diagnostics, clarifying pathways to clinical use http://t.co/7Q8WwUTs #omics #genomics #applied #science #iom #etech #trends
Digital Pathology Blog: CBLPath Receives Approval From New York State Department of Health for XALKORI(R) Companion Diagnostic
tissuepathology.com — “CBLPath recently announced it is one of a select few labs within the United States to offer Vysis(R) ALK Break Apart fluorescence in situ hybridization (FISH) testing for non-small cell lung carcinoma (NSCLC). The Vysis ALK FISH test detects rearrangements...” View full resource at tissuepathology.com
Most Recently Shared on March 26, 2012 at 8:34 pm By:
tissuepathology Doctor, Pathologist, and Physician
CBLPath Receives Approval From New York State Department of Health for XALKORI(R) Companion Diagnostic http://t.co/TQfb0wWk
Ariosa completes clinical validation study for Harmony Prenatal Test
news-medical.net — “Ariosa Diagnostics (formerly Aria Diagnostics), a molecular diagnostics company, today announced the completion of its clinical validation study for the Harmony Prenatal Test.” View full resource at news-medical.net
Most Recently Shared on March 26, 2012 at 5:15 pm By:
Ariosa completes clinical validation study for Harmony Prenatal Test: Ariosa Diagnostics (formerly Aria Diagnost... http://t.co/su9c03SL
American College of Cardiology Poster Abstract Shows Standard Lipid Profile Inaccurate for LDL Cholesterol Below 70 mg/dL - Drugs.com MedNews
drugs.com — “Friedewald calculation underestimates LDL cholesterol in patients with LDLc less than 70 mg dL compared to directly measured LDL using VAP Cholesterol Test Mar” View full resource at drugs.com
Most Recently Shared on March 26, 2012 at 12:06 pm By:
Drugs and Devices OW OW Health
American College of Cardiology Poster Abstract Shows Standard Lipid Profile Inaccurate for LDL Cholesterol... http://t.co/sc9p4UQi #drug
Malaria Journal | Abstract | Management of uncomplicated malaria in febrile under five-year-old children by community health workers in Madagascar: reliability of malaria rapid diagnostic tests
malariajournal.com — “Early diagnosis, as well as prompt and effective treatment of uncomplicated malaria, are essential components of the anti-malaria strategy in Madagascar to prevent severe malaria, reduce mortality and limit malaria transmission. The purpose of this study was to assess the performance of the malaria rapid diagnostic tests (RDTs) used by community health workers (CHWs) by comparing RDT results with two reference methods (microscopy and Polymerase Chain Reaction, PCR).” View full resource at malariajournal.com
Most Recently Shared on March 26, 2012 at 11:33 am By:
RDTs in community appears an effective strategy for improving febrile patient care, reducing use of anti-#malarials http://t.co/h1fATUba
Discovery Of Biomarkers For Autism Could Lead To Diagnostic Test
medicalnewstoday.com — “An important step towards developing a rapid, inexpensive diagnostic method for autism has been taken by Uppsala University, among other universities. Through advanced mass spectrometry the resear” View full resource at medicalnewstoday.com
Most Recently Shared on March 26, 2012 at 9:05 am By:
Discovery Of Biomarkers For Autism Could Lead To Diagnostic Test http://t.co/8VqVTFZQ #autism
First-Ever Prospective Diagnostic Study in Breast Cancer - MarketWatch
marketwatch.com — “First-Ever Prospective Diagnostic Study in Breast Cancer - MarketWatch” View full resource at marketwatch.com
Most Recently Shared on March 22, 2012 at 6:03 pm By:
Noushin Hart MD Doctor, Oncologist, Radiation Oncologist, and Physician
Chemotherapy May Be Safely Withheld for 'Low Risk' Patients for Breast Cancer Recurrence http://t.co/sNDxQPdH Agendia's MammaPrint Test
Guest Blog: Fallout from the Prometheus Case | IVD Technology
ivdtechnology.com — “With the U.S. Supreme Court decision on the Prometheus Laboratories-Mayo Clinic patent case finalized, intellectual property for many of the personalized medicine diagnostics will go away or be challenged. The Supreme Court's decision makes it much more important for FDA to accelerate their consideration of laboratory-developed tests (LDT).” View full resource at ivdtechnology.com
Most Recently Shared on March 22, 2012 at 5:01 pm By:
IVD Technology Health Magazine
Guest Blog: Fallout from the Prometheus Case http://t.co/298bxqrh
Leukemia: Understanding its types and treatments - ONA
oncologynurseadvisor.com — “This review describes the four major groups of leukemia, plus diagnostic tests and current and emerging treatment regimens for each group.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 22, 2012 at 12:48 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Leukemia: Understanding its types and treatments http://t.co/20hvrTEL #Leukemia
Diatherix Laboratories and Microarrays Inc. form Strategic Partnership - Yahoo! News
news.yahoo.com — “From Yahoo! News: New alliance to bring more sensitive and accurate clinical tests into physicians’ arsenal for detecting infectious diseases.Huntsville, AL (PRWEB) March 22, 2012 Diatherix Laboratories and Microarrays Inc. (MI) jointly announce they have entered a strategic partnership to develop industry leading infectious disease diagnostic assays. The ever-increasing prevalence of infectious and drug-resistant organisms requires that diagnostic platforms be highly adaptable and progressively” View full resource at news.yahoo.com
Most Recently Shared on March 22, 2012 at 7:54 am By:
Diatherix Laboratories and Microarrays Inc. form Strategic Partnership: New alliance to bring more sensitive and... http://t.co/kuRXbo3g
Mayo Clinic wins major patent case in unanimous Supreme Court ruling
medcitynews.com — “Mayo Clinic vs. Prometheus ends with the Supreme Court agreeing with Mayo about diagnostic tests. Read more about the case.” View full resource at medcitynews.com
Most Recently Shared on March 21, 2012 at 3:26 pm By:
Scott Strumello Patient Expert
Mayo Clinic wins major patent case with unanimous Supreme Court decision http://t.co/44SjDocj via @MedCityNews
Supreme Court Rejects Patent Protections for Certain Diagnostic Tests - California Healthline
californiahealthline.org — “Yesterday, the Supreme Court ruled that companies cannot obtain patent protection for screening tests that help doctors determine dosages, treatment options or disease risks. The case stems from a lawsuit that Prometheus Laboratories filed against Mayo Clinic. Reuters et al.” View full resource at californiahealthline.org
Most Recently Shared on March 21, 2012 at 3:23 pm By:
CaliforniaHealthline Health Organization
Supreme Court Rejects Patent Protections for Certain Diagnostic Tests - http://t.co/cWJuErjX
Advertisement
